Brinckerhoff and Best Quoted on Tafas v. Doll
March 27, 2009
Life Sciences Law & Industry Report
Foley Partner and vice-chair of the Chemical & Pharmaceutical Practice Courtenay Brinckerhoff and Partner George Best were quoted in an article titled “Federal Circuit’s Tafas Decision Could Affect Life Sciences Patents Adversely, Experts Say” in the March 27, 2009 issue of BNA’s Life Sciences Law & Industry Report.
Reproduced with permission from BNA’s Life Sciences Law & Industry Report, by The Bureau of National Affairs, Inc. http://www.bna.com.
People
Related News
August 8, 2025
In the News
Gregory Husisian and David Simon Uncover the High Stakes of Tariff Evasion
Foley & Lardner LLP partners Gregory Husisian and David Simon are featured for their insights on how the U.S. government is cracking down on tariff evaders in the Newsweek article, "America Is Making Billions From Catching 'Tariff Cheaters.'"
August 7, 2025
In the News
Kyle Faget Weighs in on Trump Pharma Tariffs
Foley & Lardner LLP partner Kyle Faget assessed the Trump administration's implementation of import tariffs on the pharmaceutical industry in the Pharma Life Sciences article, "Trump's pharma import tariffs threaten drug pricing, generics."
August 5, 2025
In the News
Aaron Maguregui on Health Data Sharing Plan – 'I would expect the FTC to be heavily involved'
Foley & Lardner LLP partner Aaron Maguregui addressed a new health care data sharing initiative announced by the federal government in the Bloomberg Law article, "Digital Data-Sharing Plan Tests Limits of Health Privacy Rules."